RALEIGH, N.C., Feb. 9, 2015 (GLOBE NEWSWIRE) -- Islet Sciences, Inc. (OTCQB:ISLT) ("Islet Sciences"), a biopharmaceutical company developing new medicines and technologies for the treatment of metabolic disease, announced today the engagement of Summer Street Research Partners ("Summer Street"), a leading healthcare-focused investment bank, as financial advisor.
Summer Street is a full service investment bank focused exclusively on the healthcare sector and is engaged in a broad range of securities activities and financial services, including investment banking, equity research, and institutional sales, trading and market making.
Summer Street will assist Islet Sciences with its strategy to complete a transaction with BHV Pharma and secure capital to fund the Company's business plan.
About Islet Sciences
Islet Sciences, Inc., a biopharmaceutical company based in Raleigh, NC, is developing new medicines and technologies for the treatment of metabolic disease. For more information, please visit http://www.isletsciences.com.
No Offer to Sell or Solicitation
This press release is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities.
Statements contained in this press release that refer to Islet Sciences' estimated or anticipated future results, possible or anticipated synergies from the transactions described above, or other non-historical facts are forward-looking statements that reflect Islet Sciences' current perspective of existing information as of the date hereof and involve certain risks and uncertainties. Actual results, including the results of the transactions described above, could differ materially from those anticipated in these forward-looking statements as a result of various factors and such forward-looking statements are not predictions of future events. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include risks described in the Islet Sciences' reports filed with the SEC.
CONTACT: Steven Delmar Chief Financial Officer 6601 Six Forks Rd. Suite 140 Raleigh, NC 27614 email@example.com (919) 480-1518Source:Islet Sciences, Inc.